| Primary |
| Colon Cancer |
26.8% |
| Rectal Cancer |
19.5% |
| Large Intestine Carcinoma |
10.8% |
| Premedication |
10.1% |
| Colon Cancer Metastatic |
7.1% |
| Rectal Cancer Metastatic |
4.1% |
| Hypertension |
3.1% |
| Rectal Cancer Recurrent |
2.6% |
| Constipation |
2.4% |
| Cancer Pain |
2.2% |
| Gastric Cancer |
1.8% |
| Nausea |
1.8% |
| Colon Cancer Recurrent |
1.3% |
| Insomnia |
1.1% |
| Prophylaxis Of Nausea And Vomiting |
1.1% |
| Gastritis Prophylaxis |
1.0% |
| Pyrexia |
0.9% |
| Diabetes Mellitus |
0.8% |
| Diarrhoea |
0.7% |
| Stomatitis |
0.7% |
|
| White Blood Cell Count Decreased |
13.0% |
| Gastrointestinal Perforation |
7.7% |
| Shock |
7.7% |
| Vomiting |
6.9% |
| Hyperammonaemia |
6.5% |
| Small Intestinal Perforation |
6.5% |
| Renal Failure Acute |
6.1% |
| Interstitial Lung Disease |
5.3% |
| Neutrophil Count Decreased |
5.3% |
| Disseminated Intravascular Coagulation |
4.9% |
| Peritonitis |
3.7% |
| Altered State Of Consciousness |
3.3% |
| Ileal Perforation |
3.3% |
| Rectal Perforation |
3.3% |
| Thrombocytopenia |
3.3% |
| Death |
2.8% |
| Hepatic Encephalopathy |
2.8% |
| Neutropenia |
2.8% |
| Anaphylactic Shock |
2.4% |
| Bone Marrow Failure |
2.4% |
|
| Secondary |
| Colon Cancer |
40.8% |
| Rectal Cancer |
24.9% |
| Colon Cancer Metastatic |
8.5% |
| Large Intestine Carcinoma |
4.0% |
| Rectal Cancer Metastatic |
4.0% |
| Drug Use For Unknown Indication |
2.6% |
| Premedication |
2.3% |
| Colon Cancer Recurrent |
2.3% |
| Rectal Cancer Recurrent |
2.0% |
| Colorectal Cancer |
1.5% |
| Pyrexia |
0.9% |
| Colorectal Cancer Metastatic |
0.9% |
| Prophylaxis Of Nausea And Vomiting |
0.8% |
| Gastric Cancer |
0.8% |
| Hypertension |
0.7% |
| Prophylaxis |
0.7% |
| Rash |
0.7% |
| Cancer Pain |
0.6% |
| Subclavian Vein Thrombosis |
0.5% |
| Constipation |
0.5% |
|
| White Blood Cell Count Decreased |
26.3% |
| Interstitial Lung Disease |
10.4% |
| Vomiting |
10.0% |
| Pyrexia |
9.4% |
| Stomatitis |
4.8% |
| Platelet Count Decreased |
4.6% |
| Renal Failure Acute |
4.2% |
| Anaphylactic Shock |
3.8% |
| Neutrophil Count Decreased |
3.8% |
| Neuropathy Peripheral |
3.2% |
| Shock |
2.8% |
| Varices Oesophageal |
2.8% |
| Convulsion |
2.2% |
| Hyperammonaemia |
2.2% |
| Peritonitis |
2.2% |
| Respiratory Failure |
1.6% |
| Sepsis |
1.6% |
| Shock Haemorrhagic |
1.6% |
| Angina Pectoris |
1.4% |
| Disease Progression |
1.4% |
|
| Concomitant |
| Colon Cancer Metastatic |
29.0% |
| Rectal Cancer Metastatic |
11.1% |
| Colon Cancer |
10.6% |
| Drug Use For Unknown Indication |
8.6% |
| Colon Cancer Recurrent |
8.4% |
| Large Intestine Carcinoma |
8.0% |
| Rectal Cancer Recurrent |
5.5% |
| Rectal Cancer |
3.8% |
| Prophylaxis |
2.8% |
| Prophylaxis Of Nausea And Vomiting |
2.7% |
| Colorectal Cancer |
2.0% |
| Constipation |
1.1% |
| Yolk Sac Tumour Site Unspecified |
1.1% |
| Hypertension |
1.0% |
| Colorectal Cancer Metastatic |
0.8% |
| Chemotherapy |
0.7% |
| Diabetes Mellitus |
0.7% |
| Small Intestine Carcinoma Metastatic |
0.7% |
| Gastritis Prophylaxis |
0.5% |
| Infection Prophylaxis |
0.5% |
|
| Interstitial Lung Disease |
13.9% |
| Peritonitis |
7.5% |
| Stomatitis |
7.1% |
| Small Intestinal Perforation |
6.4% |
| Sepsis |
6.0% |
| Disseminated Intravascular Coagulation |
5.6% |
| Vomiting |
5.6% |
| Large Intestine Perforation |
5.3% |
| Pericardial Effusion |
4.5% |
| Septic Shock |
4.1% |
| Nephrotic Syndrome |
3.8% |
| Neutrophil Count Decreased |
3.8% |
| Osteonecrosis Of Jaw |
3.8% |
| Pneumonia |
3.8% |
| Gastrointestinal Perforation |
3.4% |
| Shock |
3.4% |
| Anaphylactic Shock |
3.0% |
| Disease Progression |
3.0% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
3.0% |
| Renal Failure Acute |
3.0% |
|
| Interacting |
| Rectal Cancer |
25.0% |
| Antiemetic Supportive Care |
16.7% |
| Colorectal Cancer Recurrent |
16.7% |
| Premedication |
16.7% |
| Hyperlipidaemia |
8.3% |
| Hypertension |
8.3% |
| Product Used For Unknown Indication |
8.3% |
|
| Nervous System Disorder |
50.0% |
| Stomatitis |
50.0% |
|
